Skip to Content
  • Previous Rank
    103
  • Revenues ($M)
    $71,890
  • Revenue Percent Change
    2.6%
  • Profits ($M)
    $16,540
  • Profits Percent Change
    7.3%
  • Assets ($M)
    $141,208
  • Employees
    126,400

As the world’s biggest health care products company, Johnson & Johnson has massive scope: a sampling of its products includes Benadryl, Band-Aids, Neutrogena, Tylenol, Motrin, and Listerine. How do you boost something that’s already big? Acquisitions and revenue growth (notably in beauty products). While domestic sales rose 6%, international sales decreased about 1% thanks to divestitures, currency issues, and upheaval in Venezuela. Even if the international climate gets more comfortable, the company long known for its pioneering innovation could face competition from generics that could eat into sales.

Company Information

CEO
Alex Gorsky
Sector
Health Care
Industry
Pharmaceuticals
HQ Location
New Brunswick, NJ
Websitehttp://www.jnj.com
Years on Global 500 List17
Employees126,400
Created with sketchtool.Created with sketchtool.Looking for leads, investment insights, or competitive intelligence?Purchase Now

Johnson & Johnson Rank History

placeholder

Key Financials (Last Fiscal Year)

($ Millions)% change
Revenues ($M)$71,8902.6%
Profits ($M)$16,5407.3%
Assets ($M)$141,208-
Total Stockholder Equity ($M)$70,418-

Profit Ratios

Profit as % of Revenues23%
Profits as % of Assets11.7%
Profits as % of Stockholder Equity23.5%